Back
ESC Premium Access

Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity

Session: Myocardial and pericardial disease e-posters
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor Y. Shimada (New York, US)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Yuichi J Shimada

Columbia University Medical Center, New York (United States of America)
0 follower

93 more presentations in this session

Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course

Speaker: Professor O. Blagova (Moscow, RU)

Access
Abstract
Slides
Thumbnail

Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy

Speaker: Doctor D. Lawin (Bielefeld, DE)

Access
Abstract
Slides
Thumbnail

Cardiac rupture - the most serious complication of takotsubo syndrome

Speaker: Doctor M. Zalewska-Adamiec (Bialystok, PL)

Access
Abstract
Slides
Thumbnail

Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..

Speaker: Professor O. Blagova (Moscow, RU)

Access
Abstract
Slides
Thumbnail

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Trongtorsak (Evanston, US)

Access
Abstract
Slides
Thumbnail

Access the full session

Myocardial and pericardial disease e-posters

Speakers: Doctor Y. Shimada, Professor O. Blagova, Doctor D. Lawin, Doctor M. Zalewska-Adamiec, Professor O. Blagova...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry

27 August 2021

ESC Premium Access

Real-world clinical outcomes and anticoagulant therapy in elderly non-valvular atrial fibrillation patients with heart failure: sub-analysis of the ANAFIE Registry

27 August 2021

ESC Premium Access

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

27 August 2021

ESC 365 is supported by

logo Novo Nordisk